148 related articles for article (PubMed ID: 25880264)
1. Survey nonresponders incurred higher medical utilization and lower medication adherence.
Rinne ST; Wong ES; Lemon JM; Perkins M; Bryson CL; Liu CF
Am J Manag Care; 2015 Jan; 21(1):e1-8. PubMed ID: 25880264
[TBL] [Abstract][Full Text] [Related]
2. Medical utilization and costs associated with statin adherence in Medicaid enrollees with type 2 diabetes.
Wu J; Seiber E; Lacombe VA; Nahata MC; Balkrishnan R
Ann Pharmacother; 2011 Mar; 45(3):342-9. PubMed ID: 21325098
[TBL] [Abstract][Full Text] [Related]
3. Glucose control and medication adherence among veterans with diabetes and serious mental illness: does collocation of primary care and mental health care matter?
Long JA; Wang A; Medvedeva EL; Eisen SV; Gordon AJ; Kreyenbuhl J; Marcus SC
Diabetes Care; 2014 Aug; 37(8):2261-7. PubMed ID: 24879839
[TBL] [Abstract][Full Text] [Related]
4. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
[TBL] [Abstract][Full Text] [Related]
5. Does medication adherence lead to lower healthcare expenses for patients with diabetes?
Cheng SH; Chen CC; Tseng CH
Am J Manag Care; 2013 Aug; 19(8):662-70. PubMed ID: 24304214
[TBL] [Abstract][Full Text] [Related]
6. Treatment adherence in newly diagnosed type 2 diabetes: patient characteristics and long-term impact of adherence on inpatient care utilization.
Sun P; Lian J
Postgrad Med; 2016 May; 128(4):338-45. PubMed ID: 26849064
[TBL] [Abstract][Full Text] [Related]
7. Survey nonresponders to a medication-beliefs survey have worse adherence and persistence to chronic medications compared with survey responders.
Gadkari AS; Pedan A; Gowda N; McHorney CA
Med Care; 2011 Oct; 49(10):956-61. PubMed ID: 21666513
[TBL] [Abstract][Full Text] [Related]
8. Adherence to Oral Antihyperglycemic Agents Among Older Adults With Mental Disorders and Its Effect on Health Care Costs, Quebec, Canada, 2005-2008.
Gentil L; Vasiliadis HM; Préville M; Berbiche D
Prev Chronic Dis; 2015 Dec; 12():E230. PubMed ID: 26719900
[TBL] [Abstract][Full Text] [Related]
9. Association of Integrated Team-Based Care With Health Care Quality, Utilization, and Cost.
Reiss-Brennan B; Brunisholz KD; Dredge C; Briot P; Grazier K; Wilcox A; Savitz L; James B
JAMA; 2016 Aug 23-30; 316(8):826-34. PubMed ID: 27552616
[TBL] [Abstract][Full Text] [Related]
10. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data.
Lee WC; Balu S; Cobden D; Joshi AV; Pashos CL
Clin Ther; 2006 Oct; 28(10):1712-25; discussion 1710-1. PubMed ID: 17157128
[TBL] [Abstract][Full Text] [Related]
11. Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in Medicaid-enrolled patients with type 2 diabetes mellitus.
Balkrishnan R; Arondekar BV; Camacho FT; Shenolikar RA; Horblyuk R; Anderson RT
Clin Ther; 2007 Jun; 29(6 Pt 1):1306-15. PubMed ID: 18036392
[TBL] [Abstract][Full Text] [Related]
12. Healthcare costs and prescription adherence with introduction of thiazolidinedione therapy in Medicaid type 2 diabetic patients: a retrospective data analysis.
Balkrishnan R; Rajagopalan R; Shenolikar RA; Camacho FT; Whitmire JT; Anderson RT
Curr Med Res Opin; 2004 Oct; 20(10):1633-40. PubMed ID: 15462696
[TBL] [Abstract][Full Text] [Related]
13. Impact of type 2 diabetes medication cost sharing on patient outcomes and health plan costs.
Thornton Snider J; Seabury S; Lopez J; McKenzie S; Goldman DP
Am J Manag Care; 2016 Jun; 22(6):433-40. PubMed ID: 27355811
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Dual Health Care System Use for Obtaining Prescription Medications on Nonadherence in Veterans With Type 2 Diabetes.
Taber DJ; Ward R; Axon RN; Walker RJ; Egede LE; Gebregziabher M
Ann Pharmacother; 2019 Jul; 53(7):675-682. PubMed ID: 30724092
[TBL] [Abstract][Full Text] [Related]
15. Clinical and economic outcomes of multiple versus single long-acting inhalers in COPD.
Yu AP; Guérin A; de Leon DP; Ramakrishnan K; Wu EQ; Mocarski M; Blum SI; Setyawan J
Respir Med; 2011 Dec; 105(12):1861-71. PubMed ID: 21807487
[TBL] [Abstract][Full Text] [Related]
16. A retrospective database analysis of neuropathic pain and oral antidiabetic medication use and adherence among Texas adults with type 2 diabetes enrolled in Medicaid.
Oladapo AO; Barner JC; Rascati KL; Strassels SA
Clin Ther; 2012 Mar; 34(3):605-13. PubMed ID: 22386828
[TBL] [Abstract][Full Text] [Related]
17. Economic outcomes of exenatide vs liraglutide in type 2 diabetes patients in the United States: results from a retrospective claims database analysis.
Pelletier EM; Pawaskar M; Smith PJ; Best JH; Chapman RH
J Med Econ; 2012; 15(6):1039-50. PubMed ID: 22533526
[TBL] [Abstract][Full Text] [Related]
18. Medicaid beneficiaries with congestive heart failure: association of medication adherence with healthcare use and costs.
Esposito D; Bagchi AD; Verdier JM; Bencio DS; Kim MS
Am J Manag Care; 2009 Jul; 15(7):437-45. PubMed ID: 19589011
[TBL] [Abstract][Full Text] [Related]
19. Treatment satisfaction of diabetic patients: what are the contributing factors?
Biderman A; Noff E; Harris SB; Friedman N; Levy A
Fam Pract; 2009 Apr; 26(2):102-8. PubMed ID: 19254969
[TBL] [Abstract][Full Text] [Related]
20. Oral antidiabetic drug use and associated health outcomes in cancer patients.
Tan X; Feng X; Chang J; Higa G; Wang L; Leslie D
J Clin Pharm Ther; 2016 Oct; 41(5):524-31. PubMed ID: 27453485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
